BUD13-APOA5 Fusion FISH Probe
The BUD13-APOA5 Fusion FISH Probe is used to confirm a fusion of the BUD13 and APOA5 genes. The fusion of the BUD13 and APOA5 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| BUD13-APOA5-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-RERE | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-REOR | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-REGO | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-REGR | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-OROR | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-GORE | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-GROR | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| BUD13-APOA5-20-AQAQ | 20 (40 μL) | 200 μL |
|
BUD13 Gene Summary
The BUD13 Homolog (BUD13) gene is located on chr11 :116618885-116643714 at 11q23.3.
Gene Name: BUD13 Homolog
Chromosome: CHR11: 116618885 -116643714
Locus: 11q23.3
APOA5 Gene Summary
The protein encoded by this gene is an apolipoprotein that plays an important role in regulating the plasma triglyceride levels, a major risk factor for coronary artery disease. It is a component of high density lipoprotein and is highly similar to a rat protein that is upregulated in response to liver injury. Mutations in this gene have been associated with hypertriglyceridemia and hyperlipoproteinemia type 5. This gene is located proximal to the apolipoprotein gene cluster on chromosome 11q23. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Oct 2009]
Gene Name: Apolipoprotein A5
Chromosome: CHR11: 116660085 -116663136
Locus: 11q23.3
Gene Diseases
The BUD13 APOA5 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|